Healthcare provider profile · identity verified

David Gearhart Richards, MD

Internal Medicine · DE PERE, WI · NPI 1790719201

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	785	203
Levothyroxine Sodium	Levothyroxine Sodium	599	134
Amlodipine Besylate	Amlodipine Besylate	487	127
Lisinopril	Lisinopril	415	109
Losartan Potassium	Losartan Potassium	372	95
Simvastatin	Simvastatin	372	90
Omeprazole	Omeprazole	345	97
Metoprolol Succinate	Metoprolol Succinate	320	84
Potassium Chloride	Potassium Chloride	295	71
Rosuvastatin Calcium	Rosuvastatin Calcium	265	83
Atenolol	Atenolol	261	66
Furosemide	Furosemide	246	60
Tamsulosin Hcl	Tamsulosin Hcl	227	62
Glipizide Er	Glipizide	223	55
Hydrochlorothiazide	Hydrochlorothiazide	222	58
Allopurinol	Allopurinol	199	50
Escitalopram Oxalate	Escitalopram Oxalate	196	40
Pantoprazole Sodium	Pantoprazole Sodium	185	50
Alprazolam	Alprazolam	183	52
Metformin Hcl Er	Metformin Hcl	178	53
Metformin Hcl	Metformin Hcl	162	47
Meloxicam	Meloxicam	161	47
Albuterol Sulfate Hfa	Albuterol Sulfate	140	51
Prednisone	Prednisone	140	83
Oxybutynin Chloride Er	Oxybutynin Chloride	138	40
Eliquis	Apixaban	136	30
Lorazepam	Lorazepam	136	24
Metoprolol Tartrate	Metoprolol Tartrate	136	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	125	30
Gabapentin	Gabapentin	117	35
Fluticasone Propionate	Fluticasone Propionate	114	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	114	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	110	34
Sertraline Hcl	Sertraline Hcl	99	30
Warfarin Sodium	Warfarin Sodium	99	20
Finasteride	Finasteride	93	23
Donepezil Hcl	Donepezil Hcl	92	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	89	20
Montelukast Sodium	Montelukast Sodium	87	25
Trazodone Hcl	Trazodone Hcl	87	24
Clopidogrel	Clopidogrel Bisulfate	83	23
Enalapril Maleate	Enalapril Maleate	81	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	25
Fluoxetine Hcl	Fluoxetine Hcl	78	20
Zolpidem Tartrate	Zolpidem Tartrate	76	21
Pravastatin Sodium	Pravastatin Sodium	71	21
Ezetimibe	Ezetimibe	69	21
Famotidine	Famotidine	68	18
Januvia	Sitagliptin Phosphate	64	14
Synthroid	Levothyroxine Sodium	64	16
Glipizide	Glipizide	60	16
Clonazepam	Clonazepam	59	13
Duloxetine Hcl	Duloxetine Hcl	56	14
Tramadol Hcl	Tramadol Hcl	56	17
Venlafaxine Hcl Er	Venlafaxine Hcl	56	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	17
Carvedilol	Carvedilol	53	14
Amoxicillin	Amoxicillin	51	27
Memantine Hcl Er	Memantine Hcl	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Lovastatin	Lovastatin	44	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	11
Diclofenac Sodium	Diclofenac Sodium	39	16
Alendronate Sodium	Alendronate Sodium	38	suppressed
Levetiracetam	Levetiracetam	37	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Meclizine Hcl	Meclizine Hcl	36	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	27
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Azithromycin	Azithromycin	33	33
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	22
Celecoxib	Celecoxib	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Gemfibrozil	Gemfibrozil	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Diazepam	Diazepam	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Nystatin	Nystatin	26	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	12
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	14
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Potassium Citrate Er	Potassium Citrate	21	suppressed
Indapamide	Indapamide	20	suppressed
Ondansetron Odt	Ondansetron	20	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Valsartan	Valsartan	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Dilantin	Phenytoin Sodium Extended	16	suppressed
Donepezil Hcl Odt	Donepezil Hcl	16	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Digoxin	Digoxin	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Estradiol	Estradiol	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cephalexin	Cephalexin	13	13
Epinephrine	Epinephrine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Niacin Er	Niacin	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Ramipril	Ramipril	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Temazepam	Temazepam	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error